We had previously shown the effectiveness of sclareol in reducing the tumor volume, suppressing the regulatory T cells and shifting the cytokine profile with decreasing interleukin-4 (IL-4) and augmenting IFN-γ (18). The gene discussed is IL4; the disease is neoplasm.